Not even tempting Dartboard. If the results of phase 2b are similar to 2a, 1b and 1a then the sp will fly past $2.25.
I have no idea what the results of the trial are but I do recognise trends when I see them. Unless they have altered the drug significantly since the phase 1 trials then I see no reason why the results of a large human trial wouldn't follow the same trend of previous smaller trials involving animals and humans.
We'll know soon enough.
- Forums
- ASX - By Stock
- rebalance
Not even tempting Dartboard. If the results of phase 2b are...
Featured News
Add MBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online